Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health


Personal tools

You are here: Home / Biomarkers / ST14



This biomarker is also known as:
  • tumor associated differentially expressed gene 15 protein,
  • Matriptase,
  • MTSP1,
  • Q9Y5Y6,
  • EC 3.4.21,
  • PRSS14,
  • Membrane-type serine protease 1,
  • Tumor-associated differentially-expressed gene 15 protein,
  • Serine protease 14,
  • TMPRSS14,
  • Prostamin,
  • TADG15,
  • suppression of tumorigenicity 14 (colon carcinoma),
  • SNC19,
  • suppression of tumorigenicity 14 (colon carcinoma, matriptase, epithin),
  • HAI,
  • MT-SP1,
  • prostamin,
  • EC,
  • OTTHUMP00000230932,
  • OTTHUMP00000230931,
  • suppressor of tumorigenicity 14 protein,
  • Serine protease TADG-15,

View in BioMuta


ST14 protein is an epithelial-derived, integral membrane serine protease and is found to be activated by sphingosine 1-phosphate. The expression of this protease has been associated with breast, colon, prostate, and ovarian tumors, which implicates its role in cancer invasion, and metastasis.


QA State: Curated
Type: Protein
Short Name:
HGNC Name: ST14


There are no datasets associated with this biomarker.


The following organs have data associated with this biomarker…



Phase: Two
QA State: Under Review


ST14 localized to vascular-like structures in ovarian cancer but not in normal ovaries.

Performance Comment

ST14 was one of 13 genes out of 50 selected for further validation in PMID:21617380. Average expression of ST14 was significantly higher in epithelial ovarian cancer tumors than any other normal tissue tested.


This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at if you should have access to this biomarker.

2016 EDRN PI Orientation

The New and Continuing EDRN Principal Investigator Orientation will take on a date and location to be determined.